As an amino acid supplement, propionyl-L-carnitine powder is similar to a carnitine supplement, but with much more effective and stronger properties
The enhanced potency is due to the decreased binding of Long R3 IGF-1 to all known IGF binding proteins
JCI Insight 5 , e126506 (2019)
useful for upper GI targeting Troches buccal absorption, limited evidence specific to BPC-157 Who oral delivery is best suited for: Leaky gut / intestinal permeability Inflammatory bowel disease (IBD, Crohn's, ulcerative colitis) NSAID-induced gastric damage or ulcers Irritable bowel syndrome (IBS) General GI maintenance alongside other therapies Patients who cannot or will not self-inject Practical considerations: Oral bioavailability is lower for systemic goals do not expect injection-equivalent tendon or joint results Dosing protocols typically require three to ten times the injectable dose to achieve comparable GI effects Product quality varies widely in the oral supplement market sourcing from a licensed compounding pharmacy is essential Nasal BPC-157: Emerging Option, Limited Evidence Nasal BPC-157 is the third delivery route and the least established
Kidney Disease: Use cautiously in patients with severe kidney impairment
As a result of interactions such as these, the water solubility of amides is greater than that of corresponding hydrocarbons